Company Search:
Advanced Search
Sponsored Links
Biotec Pharmacon ASA Company Snapshot
Biotec Pharmacon ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biotec Pharmacon ASA with three other pharmaceutical manufacturers in Europe: Enzymatica AB (publ) of Sweden (2017 sales of 59.45 million Swedish Kronor [US$7.47 million] ), Nattopharma ASA (66.42 million Norwegian Kroner [US$8.52 million] ), and Collagen Solutions PLC which is based in the United Kingdom (£3.95 million [US$5.53 million] ).

Sales Analysis. During the year ended December of 2017, sales at Biotec Pharmacon ASA were NOK 66.69 million (US$8.55 million). This is a decrease of 7.3% versus 2016, when the company's sales were NOK 71.90 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biotec Pharmacon ASA
  Stock Performance Chart for Biotec Pharmacon ASA
  Stock Data: Recent Stock Performance:
  Current Price (2/16/2018): 6.50
(Figures in Norwegian Kroner)
1 Week 0.3%   13 Weeks -14.5%  
4 Weeks -7.1%   52 Weeks -35.0%  
Biotec Pharmacon ASA Key Data:
  Ticker: BIOTEC Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 66,686,000
(Year Ending Jan 2018).
Employees: 41
  Currency: Norwegian Kroner Market Cap: 285,640,375
  Fiscal Yr Ends: December Shares Outstanding: 43,944,673
  Share Type: Ordinaere Aksje Closely Held Shares: 13,122,013
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.